Compare TCOM & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TCOM | GEHC |
|---|---|---|
| Founded | 1999 | 1892 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Computer Software: Prepackaged Software |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.1B | 36.0B |
| IPO Year | 2003 | 2022 |
| Metric | TCOM | GEHC |
|---|---|---|
| Price | $43.57 | $82.98 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 29 | 22 |
| Target Price | $58.67 | ★ $87.85 |
| AVG Volume (30 Days) | 2.8M | ★ 4.2M |
| Earning Date | 11-24-2026 | 10-28-2026 |
| Dividend Yield | ★ 0.68% | 0.19% |
| EPS Growth | N/A | ★ 4.84 |
| EPS | N/A | ★ 3.44 |
| Revenue | N/A | ★ $20,625,000,000.00 |
| Revenue This Year | $6.70 | $6.01 |
| Revenue Next Year | $9.06 | $4.87 |
| P/E Ratio | ★ $9.06 | $24.27 |
| Revenue Growth | N/A | ★ 4.84 |
| 52 Week Low | $37.58 | $58.75 |
| 52 Week High | $79.00 | $89.77 |
| Indicator | TCOM | GEHC |
|---|---|---|
| Relative Strength Index (RSI) | 65.20 | 70.14 |
| Support Level | $38.13 | $60.90 |
| Resistance Level | $47.07 | $86.22 |
| Average True Range (ATR) | 0.86 | 2.37 |
| MACD | 0.49 | 0.67 |
| Stochastic Oscillator | 79.17 | 73.36 |
Trip.com is the largest online travel agent in China and is positioned to benefit from the country's rising demand for higher-margin outbound travel, as passport penetration is only 12% in China. The company generated about 79% of sales from accommodation reservations and transportation ticketing in 2024. The rest of the revenue comes from package tours and corporate travel. Before the pandemic in 2019, the firm generated 25% of revenue from international travel, which is important to its margin expansion.Most of its sales come from its domestic platform, but the company is expanding its overseas business. It competes in a crowded OTA industry in China, including Meituan, Alibaba-backed Fliggy, Tongcheng, and Qunar. The company was founded in 1999 and listed on the Nasdaq in December 2003.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).